FDA Inspection
Celgene CorporationCelgene Corporation – FDA Inspection, Aug 25, 2011
Record Details
This FDA Inspection record concerns Celgene Corporation, with an inspection on August 25, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Celgene Corporation
- Inspection Date
- August 25, 2011
- Product Type
- Drugs
View Company Profile
ID · a4d4a511-b283-4b0f-b4b6-c541351f88fc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 741664
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 314.81(b)(2)(viii)Post marketing study status report for other studies
- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Celgene Corporation
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 4, 2015 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| April 28, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 24, 2013 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 12, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Celgene Corporation
- FDA Inspection 934610 - 2015-08-04
- FDA Inspection 876766 - 2014-04-28
- FDA Inspection 829461 - 2013-04-24
- FDA Inspection 798629 - 2012-09-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.